Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Goeckeritz, Elisa, Kerwien, Susan, Baumann, Michael, Wigger, Marion, Vondey, Verena, Neumann, Lars, Landwehr, Thomas, Wendtner, Clemens M., Klein, Christian ORCID: 0000-0001-7594-7280, Liu, Ningshu, Hallek, Michael, Frenzel, Lukas P. and Krause, Guenter (2015). Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells. Int. J. Cancer, 137 (9). S. 2234 - 2243. HOBOKEN: WILEY-BLACKWELL. ISSN 1097-0215

Goeckeritz, Elisa, Vondey, Verena, Guastafierro, Anna, Pizevska, Maja, Hassenrueck, Floyd, Neumann, Lars, Hallek, Michael and Krause, Guenter (2017). Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue. Br. J. Haematol., 178 (6). S. 949 - 954. HOBOKEN: WILEY. ISSN 1365-2141

Hassenrueck, Floyd, Knoedgen, Eva, Goeckeritz, Elisa, Midda, Safi Hasan ORCID: 0000-0002-2822-6293, Vondey, Verena, Neumann, Lars, Herter, Sylvia, Klein, Christian ORCID: 0000-0001-7594-7280, Hallek, Michael and Krause, Guenter (2018). Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors. Biomed Res. Int., 2018. LONDON: HINDAWI LTD. ISSN 2314-6141

Krause, Guenter, Baki, Imaan, Kerwien, Susan, Knoedgen, Eva, Neumann, Lars, Goeckeritz, Elisa, Landwehr, Thomas, Heider, Karl-Heinz and Hallek, Michael (2016). Cytotoxicity of the CD37 antibody BI 836826 against chronic lymphocytic leukaemia cells in combination with chemotherapeutic agents or PI3K inhibitors. Br. J. Haematol., 173 (5). S. 791 - 795. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141

Thesis Abstract

Neumann, Lars (2017). Functional role of PI3K-Delta in malignant B cells. Thesis Abstract, Universität zu Köln.

This list was generated on Fri Mar 29 00:29:05 2024 CET.